Date Filed | Type | Description |
10/11/2023 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
10/10/2023 |
3
| Form 3 - Initial statement of beneficial ownership of securities: |
05/19/2023 |
4
| McFarlane Neil F. (Director) has filed a Form 4 on COLLEGIUM PHARMACEUTICAL, INC
Txns:
| Granted 9,792 shares
@ $0 |
|
05/23/2022 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
04/08/2022 |
4
| McFarlane Neil F. (Director) has filed a Form 4 on COLLEGIUM PHARMACEUTICAL, INC
Txns:
| Granted 17,845 shares
@ $0 |
|
04/08/2022 |
3
| McFarlane Neil F. (Director) has filed a Form 3 on COLLEGIUM PHARMACEUTICAL, INC |
11/24/2021 |
4
| McFarlane Neil F. (CEO) has filed a Form 4 on Adamas Pharmaceuticals Inc
Txns:
| Granted 75,000 shares
@ $0 Unknown transaction of 600,000 shares
@ $0 Disposed/sold 250,000 options to buy
@ $6.25, valued at
$1.6M
Disposed/sold 200,000 options to buy
@ $1.99, valued at
$398k
|
|
03/03/2021 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
03/20/2020 |
4
| McFarlane Neil F. (CEO) has filed a Form 4 on Adamas Pharmaceuticals Inc
Txns:
| Granted 100,000 shares
@ $0 Granted 200,000 options to buy
@ $1.99, valued at
$398k
|
|
09/17/2019 |
4
| McFarlane Neil F. (CEO) has filed a Form 4 on Adamas Pharmaceuticals Inc
Txns:
| Granted 125,000 shares
@ $0 Granted 250,000 options to buy
@ $6.25, valued at
$1.6M
|
|
09/17/2019 |
3
| McFarlane Neil F. (CEO) has filed a Form 3 on Adamas Pharmaceuticals Inc |
05/16/2019 |
4
| McFarlane Neil F. (COO) has filed a Form 4 on Retrophin, Inc.
Txns:
| Sold 984 shares
@ $17.78, valued at
$17.5k
Sold 984 shares
@ $18.71, valued at
$18.4k
|
|
12/21/2018 |
4
| McFarlane Neil F. (COO) has filed a Form 4 on Retrophin, Inc.
Txns:
| Sold 4,721 shares
@ $22.0041, valued at
$103.9k
Sold 6,404 shares
@ $22.5565, valued at
$144.5k
|
|
12/20/2018 |
4
| McFarlane Neil F. (COO) has filed a Form 4 on Retrophin, Inc.
Txns:
| Granted 11,125 shares
@ $0 |
|
11/16/2018 |
4
| McFarlane Neil F. (COO) has filed a Form 4 on Retrophin, Inc.
Txns:
| Sold 9,000 shares
@ $23.6301, valued at
$212.7k
Sold 1,000 shares
@ $24.6435, valued at
$24.6k
|
|
11/14/2018 |
4
| McFarlane Neil F. (COO) has filed a Form 4 on Retrophin, Inc.
Txns:
| Granted 10,000 shares
@ $0 |
|
02/12/2018 |
4
| McFarlane Neil F. (COO) has filed a Form 4 on Retrophin, Inc.
Txns:
| Granted 2,546 shares
@ $0 |
|
08/17/2017 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
05/18/2017 |
4
| Form 4 - Statement of changes in beneficial ownership of securities |
08/15/2016 |
4
| McFarlane Neil F. (COO) has filed a Form 4 on Retrophin, Inc.
Txns:
| Granted 15,000 shares
@ $0 Granted 120,000 options to buy
@ $17.62, valued at
$2.1M
|
|
08/15/2016 |
3
| McFarlane Neil F. (COO) has filed a Form 3 on Retrophin, Inc. |